Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

Clinical impact of genomic diversity from early to advanced hepatocellular carcinoma.

Nault JC, Martin Y, Caruso S, Hirsch TZ, Bayard Q, Calderaro J, Charpy C, Copie-Bergman C, Ziol M, Bioulac-Sage P, Couchy G, Blanc JF, Nahon P, Amaddeo G, Ganne-Carrie N, Morcrette G, Chiche L, Duvoux C, Faivre S, Laurent A, Imbeaud S, Rebouissou S, Llovet J, Seror O, Letouzé E, Zucman-Rossi J.

Hepatology. 2019 Jun 17. doi: 10.1002/hep.30811. [Epub ahead of print]

PMID:
31206197
2.

Molecular and histological correlations in liver cancer.

Calderaro J, Ziol M, Paradis V, Zucman-Rossi J.

J Hepatol. 2019 Jun 10. pii: S0168-8278(19)30341-1. doi: 10.1016/j.jhep.2019.06.001. [Epub ahead of print] Review.

PMID:
31195064
3.

A Constitutional Activating MET Mutation Makes the Genetic Link between Malignancies and Chronic Inflammatory Diseases.

El Bouchtaoui M, Do Cruzeiro M, Leboeuf C, Loisel-Ferreira I, Fedronie C, Ferreira C, Ait El Far R, Ziol M, Espié M, Falgarone G, Cassinat B, Kiladjian JJ, Feugeas JP, Janin A, Bousquet G.

Clin Cancer Res. 2019 Apr 19. doi: 10.1158/1078-0432.CCR-18-3261. [Epub ahead of print]

PMID:
31004003
4.

A 17-Beta-Hydroxysteroid Dehydrogenase 13 Variant Protects From Hepatocellular Carcinoma Development in Alcoholic Liver Disease.

Yang J, Trépo E, Nahon P, Cao Q, Moreno C, Letouzé E, Imbeaud S, Bayard Q, Gustot T, Deviere J, Bioulac-Sage P, Calderaro J, Ganne-Carrié N, Laurent A, Blanc JF, Guyot E, Sutton A, Ziol M, Zucman-Rossi J, Nault JC.

Hepatology. 2019 Mar 25. doi: 10.1002/hep.30623. [Epub ahead of print]

PMID:
30908678
5.

Benign liver tumors

Blaise L, Sutter O, Ziol M, Nault JC.

Rev Prat. 2018 Dec;68(10):1119-1124. French.

PMID:
30869222
6.

Elevated adiponectin and sTNFRII serum levels can predict progression to hepatocellular carcinoma in patients with compensated HCV1 cirrhosis.

Bastard JP, Fellahi S, Audureau É, Layese R, Roudot-Thoraval F, Cagnot C, Mahuas-Bourcier V, Sutton A, Ziol M, Capeau J, Nahon P; ANRS CO12 CirVir group.

Eur Cytokine Netw. 2018 Sep 1;29(3):112-120. doi: 10.1684/ecn.2018.0413.

PMID:
30547888
7.

Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation.

Sermondade N, Sonigo C, Sifer C, Valtat S, Ziol M, Eustache F, Grynberg M.

Fertil Steril. 2019 Feb;111(2):357-362. doi: 10.1016/j.fertnstert.2018.10.018. Epub 2018 Dec 7.

PMID:
30527837
8.

Molecular classification of hepatocellular adenomas: impact on clinical practice.

Védie AL, Sutter O, Ziol M, Nault JC.

Hepat Oncol. 2018 Apr 9;5(1):HEP04. doi: 10.2217/hep-2017-0023. eCollection 2018 Jan. Review.

9.

PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases.

Yang J, Trépo E, Nahon P, Cao Q, Moreno C, Letouzé E, Imbeaud S, Gustot T, Deviere J, Debette S, Amouyel P, Bioulac-Sage P, Calderaro J, Ganne-Carrié N, Laurent A, Blanc JF, Guyot E, Sutton A, Ziol M, Zucman-Rossi J, Nault JC.

Int J Cancer. 2019 Feb 1;144(3):533-544. doi: 10.1002/ijc.31910. Epub 2018 Nov 9.

PMID:
30289982
10.

Correction to: Ileocolic intussusception due to a cecal endometriosis: Case report and review of literature.

Rivkine E, Marciano L, Polliand C, Valenti A, Ziol M, Poncelet C, Barrat C.

Diagn Pathol. 2018 Aug 24;13(1):58. doi: 10.1186/s13000-018-0723-y.

11.

Virologic control and severity of liver disease determine survival after radiofrequency ablation of hepatocellular carcinoma on cirrhosis.

Allaire M, Rekik S, Layese R, Mumana A, Guyot E, Nkontchou G, Bourcier V, Grando V, Ziol M, Nahon P, Ganne-Carrié N, Sutter O, Audureau E, Seror O, Nault JC.

Dig Liver Dis. 2019 Jan;51(1):86-94. doi: 10.1016/j.dld.2018.07.014. Epub 2018 Jul 24.

PMID:
30126822
12.

Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysis.

Nguyen-Khac E, Thiele M, Voican C, Nahon P, Moreno C, Boursier J, Mueller S, de Ledinghen V, Stärkel P, Gyune Kim S, Fernandez M, Madsen B, Naveau S, Krag A, Perlemuter G, Ziol M, Chatelain D, Diouf M.

Lancet Gastroenterol Hepatol. 2018 Sep;3(9):614-625. doi: 10.1016/S2468-1253(18)30124-9. Epub 2018 Jul 6.

PMID:
29983372
13.

Micromolecular methods for diagnosis and therapeutic strategy: a case study.

Elbouchtaoui M, Tengher I, Miquel C, Brugière C, Benbara A, Zelek L, Ziol M, Bouhidel F, Janin A, Bousquet G, Leboeuf C.

Oncotarget. 2018 Apr 27;9(32):22862-22869. doi: 10.18632/oncotarget.25161. eCollection 2018 Apr 27.

14.

Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients.

Cacoub P, Nahon P, Layese R, Blaise L, Desbois AC, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Riachi G, Calès P, Péron JM, Alric L, Bourlière M, Mathurin P, Blanc JF, Abergel A, Serfaty L, Mallat A, Grangé JD, Attali P, Bacq Y, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Capron D, Thiefin G, Zucman D, Di Martino V, Bagnis CI, Ziol M, Sutton A, Letouze E, Roudot-Thoraval F, Audureau E; ANRS CO12 CirVir group.

Am Heart J. 2018 Apr;198:4-17. doi: 10.1016/j.ahj.2017.10.024. Epub 2017 Nov 7.

PMID:
29653647
15.

Influence of Progenitor-Derived Regeneration Markers on Hepatitis C Virus-Related Cirrhosis Outcome (ANRS CO12 CirVir Cohort).

Wendum D, Layese R, Ganne-Carrié N, Bourcier V, Merabtene F, Cagnot C, Sauce E, Barget N, Bedossa P, Terris B, Selves J, Bioulac-Sage P, Sturm N, Sattonnet C, Nahon P, Roudot-Thoraval F, Ziol M; ANRS CO12 CirVir Group.

Hepatology. 2018 Oct;68(4):1534-1548. doi: 10.1002/hep.29927.

PMID:
29637581
16.

Determination of candidate metabolite biomarkers associated with recurrence of HCV-related hepatocellular carcinoma.

Liu Z, Nahon P, Li Z, Yin P, Li Y, Amathieu R, Ganne-Carrié N, Ziol M, Sellier N, Seror O, Le Moyec L, Savarin P, Xu G.

Oncotarget. 2017 Dec 15;9(5):6245-6258. doi: 10.18632/oncotarget.23500. eCollection 2018 Jan 19.

17.

Hsp72 protects against liver injury via attenuation of hepatocellular death, oxidative stress, and JNK signaling.

Levada K, Guldiken N, Zhang X, Vella G, Mo FR, James LP, Haybaeck J, Kessler SM, Kiemer AK, Ott T, Hartmann D, Hüser N, Ziol M, Trautwein C, Strnad P.

J Hepatol. 2018 May;68(5):996-1005. doi: 10.1016/j.jhep.2018.01.003. Epub 2018 Jan 11.

PMID:
29331340
18.

Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance.

Ziol M, Poté N, Amaddeo G, Laurent A, Nault JC, Oberti F, Costentin C, Michalak S, Bouattour M, Francoz C, Pageaux GP, Ramos J, Decaens T, Luciani A, Guiu B, Vilgrain V, Aubé C, Derman J, Charpy C, Zucman-Rossi J, Barget N, Seror O, Ganne-Carrié N, Paradis V, Calderaro J.

Hepatology. 2018 Jul;68(1):103-112. doi: 10.1002/hep.29762. Epub 2018 May 9.

PMID:
29281854
19.

Concomitant screening for liver fibrosis and steatosis in French type 2 diabetic patients using Fibroscan.

Roulot D, Roudot-Thoraval F, NKontchou G, Kouacou N, Costes JL, Elourimi G, Le Clesiau H, Ziol M, Beaugrand M.

Liver Int. 2017 Dec;37(12):1897-1906. doi: 10.1111/liv.13481. Epub 2017 Jul 2.

PMID:
28556413
20.

Autoimmune-like chronic hepatitis induced by olmesartan.

Barge S, Ziol M, Nault JC.

Hepatology. 2017 Dec;66(6):2086-2088. doi: 10.1002/hep.29228. Epub 2017 Oct 30. No abstract available.

PMID:
28437842
21.

Proliferation Markers Are Associated with MET Expression in Hepatocellular Carcinoma and Predict Tivantinib Sensitivity In Vitro.

Rebouissou S, La Bella T, Rekik S, Imbeaud S, Calatayud AL, Rohr-Udilova N, Martin Y, Couchy G, Bioulac-Sage P, Grasl-Kraupp B, de Koning L, Ganne-Carrié N, Nault JC, Ziol M, Zucman-Rossi J.

Clin Cancer Res. 2017 Aug 1;23(15):4364-4375. doi: 10.1158/1078-0432.CCR-16-3118. Epub 2017 Feb 28.

22.

Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications.

Nahon P, Bourcier V, Layese R, Audureau E, Cagnot C, Marcellin P, Guyader D, Fontaine H, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Leroy V, Riachi G, Calès P, Péron JM, Alric L, Bourlière M, Mathurin P, Dharancy S, Blanc JF, Abergel A, Serfaty L, Mallat A, Grangé JD, Attali P, Bacq Y, Wartelle C, Dao T, Benhamou Y, Pilette C, Silvain C, Christidis C, Capron D, Bernard-Chabert B, Zucman D, Di Martino V, Thibaut V, Salmon D, Ziol M, Sutton A, Pol S, Roudot-Thoraval F; ANRS CO12 CirVir Group.

Gastroenterology. 2017 Jan;152(1):142-156.e2. doi: 10.1053/j.gastro.2016.09.009. Epub 2016 Sep 15. Erratum in: Gastroenterology. 2019 Feb 25;:.

PMID:
27641509
23.

Reply to Rokx et al.

Le Joncour A, Bidegain F, Ziol M, Nebbad B, Galicier L, Oksenhendler E, Mechai F, Boutboul D, Bouchaud O.

Clin Infect Dis. 2016 Aug 1;63(3):428. doi: 10.1093/cid/ciw304. Epub 2016 May 8. No abstract available.

PMID:
27161782
24.

Keratin 23 is a stress-inducible marker of mouse and human ductular reaction in liver disease.

Guldiken N, Kobazi Ensari G, Lahiri P, Couchy G, Preisinger C, Liedtke C, Zimmermann HW, Ziol M, Boor P, Zucman-Rossi J, Trautwein C, Strnad P.

J Hepatol. 2016 Sep;65(3):552-9. doi: 10.1016/j.jhep.2016.04.024. Epub 2016 May 2.

PMID:
27151178
25.

Sequential Serum Metabolomic Profiling after Radiofrequency Ablation of Hepatocellular Carcinoma Reveals Different Response Patterns According to Etiology.

Goossens C, Nahon P, Le Moyec L, Triba MN, Bouchemal N, Amathieu R, Ganne-Carrié N, Ziol M, Trinchet JC, Sellier N, Diallo A, Seror O, Savarin P.

J Proteome Res. 2016 May 6;15(5):1446-54. doi: 10.1021/acs.jproteome.5b01032. Epub 2016 Apr 14.

PMID:
27015127
26.

Percutaneous Treatment of Localized Infiltrative Hepatocellular Carcinoma Developing on Cirrhosis.

Nault JC, Nkontchou G, Nahon P, Grando V, Bourcier V, Barge S, Ziol M, Sellier N, Ganne-Carrie N, Seror O.

Ann Surg Oncol. 2016 Jun;23(6):1906-15. doi: 10.1245/s10434-015-5064-4. Epub 2016 Jan 5.

PMID:
26732275
27.

Hemophagocytic Lymphohistiocytosis Associated With Bartonella henselae Infection in an HIV-Infected Patient.

Le Joncour A, Bidegain F, Ziol M, Galicier L, Oksenhendler E, Mechai F, Boutboul D, Bouchaud O.

Clin Infect Dis. 2016 Mar 15;62(6):804-6. doi: 10.1093/cid/civ999. Epub 2015 Dec 8.

PMID:
26646679
28.

Diagnostic performance of controlled attenuation parameter for predicting steatosis grade in chronic hepatitis B.

Cardoso AC, Beaugrand M, de Ledinghen V, Douvin C, Poupon R, Trinchet JC, Ziol M, Bedossa P, Marcellin P.

Ann Hepatol. 2015 Nov-Dec;14(6):826-36. doi: 10.5604/16652681.1171762.

29.

Prevalence and clinical significance of nodular regenerative hyperplasia in liver biopsies.

Barge S, Grando V, Nault JC, Broudin C, Beaugrand M, Ganne-Carrié N, Roulot D, Ziol M.

Liver Int. 2016 Jul;36(7):1059-66. doi: 10.1111/liv.12974. Epub 2015 Oct 19.

PMID:
26415006
30.

Norepinephrine Decreases Fluid Requirements and Blood Loss While Preserving Intestinal Villi Microcirculation during Fluid Resuscitation of Uncontrolled Hemorrhagic Shock in Mice.

Harrois A, Baudry N, Huet O, Kato H, Dupic L, Lohez M, Ziol M, Vicaut E, Duranteau J.

Anesthesiology. 2015 May;122(5):1093-102. doi: 10.1097/ALN.0000000000000639.

PMID:
25782753
31.

Genetic risk markers for hepatocellular carcinoma in patients with alcoholic liver disease.

Nahon P, Sutton A, Ziol M, Zucman-Rossi J, Trinchet JC, Ganne-Carrié N.

Hepat Oncol. 2015 Jan;2(1):63-78. doi: 10.2217/hep.14.26. Epub 2015 Jan 12. Review.

32.

Aseptic muscular abscesses associated with myelodysplastic syndrome.

Mirouse A, Virone A, Gobert D, Soussan M, Braun T, Ziol M, Gardin C, Fenaux P, Mekinian A, Fain O.

Eur J Dermatol. 2014 Nov-Dec;24(6):696-7. doi: 10.1684/ejd.2014.2435. No abstract available.

PMID:
25333797
33.

Predicting recurrence following radiofrequency percutaneous ablation for hepatocellular carcinoma.

Ganne-Carrié N, Nault JC, Ziol M, N'Kontchou G, Nahon P, Grando V, Bourcier V, Barge S, Beaugrand M, Trinchet JC, Seror O.

Hepat Oncol. 2014 Oct;1(4):395-408. doi: 10.2217/hep.14.22. Epub 2014 Dec 11. Review.

34.

Keratins 8 and 18 are type II acute-phase responsive genes overexpressed in human liver disease.

Guldiken N, Usachov V, Levada K, Trautwein C, Ziol M, Nahon P, Strnad P.

Liver Int. 2015 Apr;35(4):1203-12. doi: 10.1111/liv.12608. Epub 2014 Jun 26.

PMID:
24930437
35.

Impact of cytokine gene variants on the prediction and prognosis of hepatocellular carcinoma in patients with cirrhosis.

Tarhuni A, Guyot E, Rufat P, Sutton A, Bourcier V, Grando V, Ganne-Carrié N, Ziol M, Charnaux N, Beaugrand M, Moreau R, Trinchet JC, Mansouri A, Nahon P.

J Hepatol. 2014 Aug;61(2):342-50. doi: 10.1016/j.jhep.2014.04.011. Epub 2014 Apr 18.

PMID:
24751829
36.

High frequency of X chromosome abnormalities in women with short stature and elevated liver enzymes.

Roulot D, Malan V, Ziol M, Linglart A, Bourcier V, Beaugrand M, Benzacken B.

J Clin Endocrinol Metab. 2014 Aug;99(8):E1592-6. doi: 10.1210/jc.2014-1037. Epub 2014 Apr 14.

PMID:
24731013
37.

Relationship between tumor heterogeneity measured on FDG-PET/CT and pathological prognostic factors in invasive breast cancer.

Soussan M, Orlhac F, Boubaya M, Zelek L, Ziol M, Eder V, Buvat I.

PLoS One. 2014 Apr 10;9(4):e94017. doi: 10.1371/journal.pone.0094017. eCollection 2014.

38.

GH administration rescues fatty liver regeneration impairment by restoring GH/EGFR pathway deficiency.

Collin de l'Hortet A, Zerrad-Saadi A, Prip-Buus C, Fauveau V, Helmy N, Ziol M, Vons C, Billot K, Baud V, Gilgenkrantz H, Guidotti JE.

Endocrinology. 2014 Jul;155(7):2545-54. doi: 10.1210/en.2014-1010. Epub 2014 Apr 7.

PMID:
24708244
39.

Synergistic deleterious effect of hypoxemia and hypovolemia on microcirculation in intestinal villi*.

Harrois A, Baudry N, Huet O, Kato H, Lohez M, Ziol M, Duranteau J, Vicaut E.

Crit Care Med. 2013 Nov;41(11):e376-84. doi: 10.1097/CCM.0b013e318292388d.

PMID:
23963129
40.

ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma.

Ziol M, Sutton A, Calderaro J, Barget N, Aout M, Leroy V, Blanc JF, Sturm N, Bioulac-Sage P, Nahon P, Nault JC, Charnaux N, N'kontchou G, Trinchet JC, Delehedde M, Seror O, Beaugrand M, Vicaut E, Ganne-Carrié N.

J Hepatol. 2013 Dec;59(6):1264-70. doi: 10.1016/j.jhep.2013.07.030. Epub 2013 Aug 6.

PMID:
23928407
41.

Systematic cavity shaving: modifications of breast cancer management and long-term local recurrence, a multicentre study.

Héquet D, Bricou A, Koual M, Ziol M, Feron JG, Rouzier R, Brouland JP, Delpech Y, Barranger E.

Eur J Surg Oncol. 2013 Aug;39(8):899-905. doi: 10.1016/j.ejso.2013.05.012. Epub 2013 Jun 15.

PMID:
23773800
42.

Malignant transformation of abdominal wall endometriosis: case report and literature review.

Vinchant M, Poncelet C, Ziol M, Vons C, Bricou A.

Tumori. 2013 Mar-Apr;99(2):e49-54. doi: 10.1700/1283.14207. Review.

PMID:
23748829
43.

Q fever and Mediterranean spotted fever associated with hemophagocytic syndrome: case study and literature review.

Lecronier M, Prendki V, Gerin M, Schneerson M, Renvoisé A, Larroche C, Ziol M, Fain O, Mekinian A.

Int J Infect Dis. 2013 Aug;17(8):e629-33. doi: 10.1016/j.ijid.2012.12.026. Epub 2013 Feb 9. Review.

44.

Identification of serum proton NMR metabolomic fingerprints associated with hepatocellular carcinoma in patients with alcoholic cirrhosis.

Nahon P, Amathieu R, Triba MN, Bouchemal N, Nault JC, Ziol M, Seror O, Dhonneur G, Trinchet JC, Beaugrand M, Le Moyec L.

Clin Cancer Res. 2012 Dec 15;18(24):6714-22. doi: 10.1158/1078-0432.CCR-12-1099. Epub 2012 Nov 7.

45.

Peripheral intrahepatic cholangiocarcinoma occurring in patients without cirrhosis or chronic bile duct diseases: epidemiology and histopathology of distant nontumoral liver in 57 White patients.

Nkontchou G, Tran Van Nhieu J, Ziol M, Tengher I, Mahmoudi A, Roulot D, Bourcier V, Ganne Carrie N, Grando-Lemaire V, Trinchet JC, Cherqui D, Beaugrand M.

Eur J Gastroenterol Hepatol. 2013 Jan;25(1):94-8. doi: 10.1097/MEG.0b013e328357cdd7.

PMID:
23085575
46.

Hepatic endometrioma: a case report and review of the literature: report of a case.

Rivkine E, Jakubowicz D, Marciano L, Polliand C, Poncelet C, Ziol M, Barrat C.

Surg Today. 2013 Oct;43(10):1188-93. doi: 10.1007/s00595-012-0360-0. Epub 2012 Oct 19. Review.

PMID:
23080414
47.

Keratin 8 variants are infrequent in patients with alcohol-related liver cirrhosis and do not associate with development of hepatocellular carcinoma.

Usachov V, Nahon P, Lunova M, Ziol M, Rufat P, Sutton A, Beaugrand M, Strnad P.

BMC Gastroenterol. 2012 Oct 18;12:147. doi: 10.1186/1471-230X-12-147.

48.

[Realizing systematic cavity margins in conservative breast cancer surgery].

Bricou A, Héquet D, Tengher-Barna I, Ziol M, Barranger E.

Gynecol Obstet Fertil. 2012 Nov;40(11):715-9. doi: 10.1016/j.gyobfe.2012.08.003. Epub 2012 Sep 18. Review. French.

PMID:
22995051
49.

High-grade poorly differentiated retroperitoneal sarcoma. Report of a case and review of the literature.

Bossi M, Paolino LA, Valenti A, Marciano L, Polliand C, Ziol M, Barrat C.

Rom J Morphol Embryol. 2012;53(3):625-8. Review.

50.

Supplemental Content

Support Center